After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, DXCM falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Dexcom Inc is $34.67B. A total of 3.25 million shares were traded on the day, compared to an average of 4.01M shares.
In the most recent transaction, Stern Sadie sold 424 shares of DXCM for 76.87 per share on Dec 16 ’24. After the transaction, the EVP, Chief HR Officer now owns 70,768 company shares. In a previous transaction on Dec 16 ’24, Sylvain Jereme M sold 744 shares at 76.87 per share. DXCM shares that EVP, Chief Financal Officer owns now total 80,030.
Among the insiders who sold shares, Leach Jacob Steven disposed of 744 shares on Dec 16 ’24 at a per-share price of $76.87. This resulted in the EVP, Chief Operating Officer holding 264,171 shares of DXCM after the transaction. In another insider transaction, Heller Bridgette P sold 1,000 shares at $76.87 per share on Dec 16 ’24. Company shares held by the Director now total 23,349.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DXCM has a high of $142.00 and a low of $62.34.
As of this writing, DXCM has an earnings estimate of $0.5 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $0.59 per share and a lower estimate of $0.41.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.07, while its Total Shareholder’s Equity was $2.04B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.59.